Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oncoquest-L Vaccine in Follicular Lymphoma
NCT02194751Phase 2Not yet recruiting
- Sponsor
- XEME Biopharma Inc.
- Start
- Jul 2021
- Primary completion
- Jun 2024
- Modality
- Vaccines & Immunotherapeutics, Targeted Liposomes, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of Oncoquest-L vaccine in follicular lymphoma (FL), sponsored by XEME Biopharma Inc.. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
Oncoquest-L vaccine
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT02194751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02194751.